CBS 2019
CBSMD教育中心
English

ASCVD Prevention

科研文章

荐读文献

Short-Term Progression of Multiterritorial Subclinical Atherosclerosis Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes The Burden of Cardiovascular Diseases Among US States, 1990-2016 Coronary calcium as a predictor of coronary events in four racial or ethnic groups ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography Burden of Cardiovascular Diseases in China, 1990-2016: Findings From the 2016 Global Burden of Disease Study Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines The Prevalence of Myocardial Bridging Associated with Coronary Endothelial Dysfunction in Patients with Chest Pain and Non-Obstructive Coronary Artery Disease Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies

Original Research2019 Jan 15. [Epub ahead of print]

JOURNAL:EuroIntervention. Article Link

The Prevalence of Myocardial Bridging Associated with Coronary Endothelial Dysfunction in Patients with Chest Pain and Non-Obstructive Coronary Artery Disease

Sara JDS, Corban MT, Prasad M et al. Keywords: myocardial bridging; prevalence; coronary endothelial dysfunction; chest pain; angina; non obstructive CAD

ABSTRACT

AIMS - Myocardial bridging (MB), characterized by the epicardial coronary vessel diving into the myocardium, is present up to 1/3rd of adults and is associated with accelerated atherosclerosis, and angina. In the current study we determine the association between MB and coronary endothelial dysfunction.


METHODS AND RESULTS - Patients with chest pain and nonobstructive CAD (stenosis < 40%) at angiography underwent invasive assessment of endothelial function. Epicardial endothelial function was assessed by measuring the percent change in coronary artery diameter in response to intracoronary infusions of acetylcholine (%ΔCADAch). Epicardial endothelial dysfunction was defined as %ΔCADAch of < -20%. Microvascular endothelial function was assessed as the percent change in coronary blood flow in response to intracoronary infusions of acetylcholine (%ΔCBFAch), and microvascular endothelial dysfunction was defined as %ΔCBFAch of < 50%. MB was diagnosed angiographically. The frequency of epicardial and microvascular endothelial dysfunction was compared between patients with and without MB. Results Between 1993 and 2012, 1,469 patients (mean age 50.4 years, 35% male) underwent coronary angiography and invasive testing of endothelial function. Two hundred eight (14.2%) patients had MB. Patients with MB had a higher frequency of epicardial endothelial dysfunction compared to patients without MB. In multivariate analyses, MB was a significant predictor of epicardial (OR, 95% CI, 1.45, 1.05 - 2.01, p=0.026) and microvascular endothelial dysfunction (OR, 95% CI, 1.36, 1.00 - 1.85, p=0.047).


CONCLUSIONS - MB is significantly associated with epicardial and microvascular endothelial dysfunction in patients with non-obstructive CAD supporting its potential role as a mechanism for angina in symptomatic patients with MB.